Actively Recruiting
Reducing Stigma in People Who Inject Drugs With HIV Using Rapid-Start Antiretroviral Therapy A Pilot Study of the RS-ART Strategy in General and Prison Populations
Led by Yale University · Updated on 2026-09-10
135
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a rapid-start antiretroviral therapy RS-ART strategy for people who inject drugs PWID living with HIV. The study aims to develop and test this approach to reduce stigma and improve HIV treatment initiation timing, focusing on starting ART within 7 days of diagnosis. The trial includes both the general PWID population and prisoners, with the goal of assessing how this intervention affects stigma and health behaviors. Participants will receive the RS-ART strategy as part of routine care, guided by prescribing physicians who follow a protocol informed by earlier study phases. The intervention emphasizes clinical decision-making based on medical criteria to initiate ART promptly, with additional support for mental health and treatment adherence provided after ART begins. Surveys on stigma and health behaviors will be collected at baseline, 1, 3, and 6 months, alongside viral load data from medical records. During the study, participants will complete surveys to capture their experiences related to stigma and substance use at multiple time points. Researchers will review viral load outcomes six months after starting ART to evaluate treatment impact. The study is designed as a non-randomized, parallel trial without masking and will run until May 2028, with all assessments aligned with routine clinical care to minimize disruption.
CONDITIONS
Brief Title
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Research Team
D
David Oliveros Gómez, MPH
D
Daniel J Bromberg, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here